NEVRO CORP. SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
Exhibit 10.6(c)
NEVRO CORP.
SECOND AMENDMENT TO
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
This Second Amendment to Amended and Restated Registration Rights Agreement (this Second Amendment), by and among Nevro Corp., a Delaware corporation (the Company), and the undersigned stockholders of the Company is made and entered into as of October 24, 2014, with respect to that certain Amended and Restated Registration Rights Agreement, dated as of February 8, 2013, as amended on March 5, 2013, by and among the Company and each of the stockholders of the Company listed on Exhibit A thereto, as such Exhibit A may be amended from time to time (the Stockholders) (as previously amended, the Original Agreement). Capitalized terms used in this Second Amendment and not otherwise defined shall have the meaning ascribed to them in the Original Agreement.
RECITALS
WHEREAS, the Company and the undersigned Stockholders desire to amend the Original Agreement in certain respects as set forth herein.
WHEREAS, pursuant to Section 14.3 of the Original Agreement, the provisions of the Original Agreement may be amended or waived at any time by the written agreement of the Company and Stockholders holding at least 70% of the Registrable Securities.
WHEREAS, any amendment or waiver effected in accordance with Section 14.3 of the Original Agreement shall be binding upon each holder of Registrable Securities and the Company.
WHEREAS, the undersigned Stockholders hold, in the aggregate, not less than 70% of the Registrable Securities, voting together as a single class on an as-converted basis.
AGREEMENT
NOW, THEREFORE, in consideration of the recitals and the mutual premises, covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
1. Amendments.
(A). The definition of Qualified IPO in Section 1 of the Original Agreement is hereby amended to read as follows:
Qualified IPO means a firm commitment underwritten public offering of Common Stock of the Company that yields net proceeds to the Company of not less than $50,000,000 (before deduction of underwriters commissions and expenses); provided, however, that if such offering is consummated after March 31, 2015, such offering must also be at an equivalent price per share of Common Stock of not less than 2.5 times the
Series C Original Issue Price (as adjusted for any equity split, equity combination, in-kind equity distribution, recapitalization or similar transaction).
2. Reference to and Effect on the Original Agreement. On or after the date hereof, each reference in the Original Agreement to this Agreement, hereunder, herein or words of like import shall mean and be a reference to the Original Agreement as amended hereby. No reference to this Second Amendment need be made in any instrument or document at any time referring to the Original Agreement, a reference to the Agreement, in any of such to be deemed a reference to the Original Agreement as amended hereby.
3. No Other Amendments. Except as set forth herein, the Original Agreement shall remain in full force and effect in accordance with its terms.
4. Counterparts. This Second Amendment may be executed in any number of counterparts, each of which may be executed by less than all of the parties necessary to give effect to this Second Amendment, each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one instrument.
5. Headings. All section headings herein are inserted for convenience only and shall not modify or affect the construction or interpretation of any provisions of this Second Amendment or the Original Agreement.
6. Governing Law. This Second Amendment and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.
(Signature Pages Follow)
2
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| NEVRO CORP. | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ Michael DeMane | |
|
|
| Name: | Michael DeMane |
|
|
| Title: | Chief Executive Officer |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| NOVO A/S | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ Thomas Dyrberg MD | |
|
|
| Name: | Thomas Dyrberg MD |
|
|
| Title: | Senior Partner |
|
|
|
|
|
|
|
|
|
|
|
| Address: | Novo Ventures | |
|
|
| Tuborg Havnevej 19 | |
|
|
| DK-2900 Hellerup | |
|
|
| Denmark |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| JOHNSON & JOHNSON DEVELOPMENT CORPORATION | |||
|
|
| |||
|
|
| |||
|
|
| By: | /s/ Michael P. Chuisano | |
|
|
| Name: | Michael P. Chuisano | |
|
|
| Title: | Vice President and COO | |
|
|
| |||
|
|
|
| ||
|
| Address: | 410 George St. | ||
|
|
| New Brunswick, NJ 08901 | ||
|
|
|
| ||
|
|
|
| ||
|
| With a Copy to: | Assistant General Counsel | ||
|
|
| One Johnson & Johnson Plaza | ||
|
|
| New Brunswick, NJ 08933 | ||
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| ABERDARE VENTURES III, LP | ||
|
| By: | Aberdare GP III, LLC | |
|
| Its: | General Partner | |
|
|
| ||
|
|
| ||
|
|
| By: | /s/ John H. Odden |
|
|
| Name: | John H. Odden |
|
|
| Title: | Manager |
|
|
| ||
|
|
| ||
|
| ABERDARE PARTNERS III, LP | ||
|
| By: | Aberdare GP III, LLC | |
|
| Its: | General Partner | |
|
|
| ||
|
|
| ||
|
|
| By: | /s/ John H. Odden |
|
|
| Name: | John H. Odden |
|
|
| Title: | Manager |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| BAY CITY CAPITAL FUND IV, L.P. | ||
|
| By: | Bay City Capital Management IV LLC | |
|
| Its: | General Partner | |
|
| By: | Bay City Capital LLC | |
|
| Its: | Manager | |
|
|
| ||
|
|
| ||
|
|
| By: | /s/ Carl Goldfischer, MD |
|
|
| Name: | Carl Goldfischer, MD |
|
|
| Title: | Manager and Managing Director |
|
|
| ||
|
|
| ||
|
| BAY CITY CAPITAL FUND IV | ||
|
| CO-INVESTMENT FUND, L.P. | ||
|
| By: | Bay City Capital Management IV LLC | |
|
| Its: | General Partner | |
|
| By: | Bay City Capital LLC | |
|
| Its: | Manager | |
|
|
| ||
|
|
| ||
|
|
| By: | /s/ Carl Goldfischer, MD |
|
|
| Name: | Carl Goldfischer, MD |
|
|
| Title: | Manager and Managing Director |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| THREE ARCH PARTNERS IV, L.P. | ||
|
| By: | Three Arch Management IV, L.L.C. | |
|
| Its: | General Partner | |
|
|
| ||
|
|
| ||
|
|
| By: | /s/ Wilfred Jaeger |
|
|
| Name: | Wilfred Jaeger |
|
|
| Title: | Managing Member |
|
|
| ||
|
|
| ||
|
| THREE ARCH ASSOCIATES IV, L.P. | ||
|
| By: | Three Arch Management IV, L.L.C. | |
|
| Its: | General Partner | |
|
|
| ||
|
|
| ||
|
|
| By: | /s/ Wilfred Jaeger |
|
|
| Name: | Wilfred Jaeger |
|
|
| Title: | Managing Member |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| MPM BIOVENTURES IV-QP, L.P. | ||
|
| By: | MPM BIOVENTURES IV GP LLC, its | |
|
| General Partner | ||
|
|
|
| |
|
| By: | MPM BIOVENTURES IV LLC, its | |
|
| Managing Member | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ James Scopa | |
|
| Name: | James Scopa | |
|
| Title: | Member | |
|
|
| ||
|
|
| ||
|
| MPM BIOVENTURES IV GMBH & CO. | ||
|
| By: | MPM BIOVENTURES IV GP LLC, in its | |
|
| capacity as the Managing Limited Partner | ||
|
|
| ||
|
| By: | MPM BIOVENTURES IV LLC, its | |
|
| Managing Member | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ James Scopa | |
|
| Name: | James Scopa | |
|
| Title: | Member | |
|
|
| ||
|
|
| ||
|
| MPM ASSET MANAGEMENT | ||
|
| By: | MPM BIOVENTURES IV LLC, its | |
|
| Manager | ||
|
|
| ||
|
|
| ||
|
| By: | /s/ James Scopa | |
|
| Name: | James Scopa | |
|
| Title: | Member | |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
|
| AMV PARTNERS II, L.P. | ||
|
| By: | Accuitive Medical Ventures II, LLC | |
|
| Its: | General Partner | |
|
|
| ||
|
|
| ||
|
|
| By: | /s/ Gordon T. Wyatt |
|
|
| Name: | Gordon T. Wyatt |
|
|
| Title: | Managing Member/CFO |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
| COVIDIEN GROUP S.A.R.L. | |
|
|
|
|
|
|
| By: | /s/ Michelangelo F. Stefani |
| Name: | Michelangelo F. Stefani |
| Title: | General Manager |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
| NEA VENTURES 2013, LIMITED PARTNERSHIP | |
|
| |
|
| |
| By: | /s/ Louis S. Citron |
| Name: | Louis S. Citron |
| Title: | Vice-President |
|
|
|
|
|
|
| NEW ENTERPRISE ASSOCIATES 14, L.P. | |
|
| |
| By: NEA Partners 14, L.P. | |
|
| |
| By: NEA 14 GP, LTD. | |
|
|
|
| Its: |
|
|
|
|
|
|
|
| By: | /s/ Louis S. Citron |
| Name: | Louis S. Citron |
| Title: | Chief Legal Officer |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
| /s/ Andrew Galligan |
| ANDREW GALLIGAN |
|
|
|
|
|
|
| ANDRE WALKER |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.
| /s/ Michael DeMane | ||
| MICHAEL DEMANE | ||
|
| ||
|
| ||
|
| THE MICHAEL F. DEMANE 2012 RETAINED ANNUITY TRUST U/A/D JULY 26, 2012 | |
|
|
| |
|
|
| |
|
| By: | /s/ Michael DeMane |
|
| Name: | Michael DeMane |
|
| Title: | Trustee |
|
|
|
|
|
|
|
|
| THE MICHAEL F. DEMANE 2013 RETAINED ANNUITY TRUST | ||
|
| ||
|
|
| |
|
| By: | /s/ Michael DeMane |
|
| Name: | Michael DeMane |
|
| Title: | Trustee |
SIGNATURE PAGE TO NEVRO CORP.
SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT